Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer
Nicole A. Traphagen(Harvard University), Myles Brown(Harvard University)
Cited by 2
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
|Cell|2009|911
Cistrome: an integrative platform for transcriptional regulation studies
|Genome biology|2011|792
Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse
|Nucleic Acids Research|2016|672